Abstract:ID 97320 Poster Board 473 For the 46 million African Americans in the United States, nearly 14 million representing ~30% of black population suffer from cardiovascular disease. Importantly, a genetic variant in aldehyde dehydrogenase 2 (ALDH2), commonly known as ALDH2*2 (rs671, E504K) exclusively present in 560 million East Asians is a risk factor for cardiovascular disease in Asians. The ALDH2*2 variant is associated with reduced ALDH2 enzymatic activity in vitro and in vivo , and leads to acetaldehyde accumulation following alcohol consumption. However, it is not well understood whether ALDH2 genetic variants carried by the Black population leads to impaired acetaldehyde metabolism after alcohol intake. Here we hypothesize that ALDH2 variants carried by Blacks can lead to impaired acetaldehyde metabolism in vitro . To test this hypothesis, we discovered using a worldwide Genome Aggregation Database, gnomAD, that ALDH2 variants also exist in Blacks. Here we identified eight Black ALDH2 variants in the gnomAD database which we characterized in vitro . As an initial step, we constructed the variants by site directed mutagenesis, expressed, purified and tested their enzymatic activity to metabolize acetaldehyde. Our in vitro results showed that K155T and R268C ALDH2 proteins are essentially inactive (0.03±0.01 and 0.01±0.00 versus 1.52±0.14 mmol/min/mg for wild-type protein). V80A, F87L and R95C had significantly reduced enzymatic activity relative to the wild type (0.11±0.03, 0.22±0.03 and 0.15±0.06 versus 1.52±0.14 mmol/min/mg for wild-type protein). In addition, I41V, R103W and D299N exhibited 50-70% wild type activity (1.13±0.10, 0.84±0.07 and 0.80±0.16 versus 1.52±0.14 mmol/min/mg for wild-type protein). Furthermore, wild type (3.31±0.22 versus 1.52±0.14 mmol/min/mg for untreated protein), I41V (2.86±0.13 versus 1.13±0.10 mmol/min/mg for untreated protein), V80A (0.33±0.05 versus for 0.11±0.03 mmol/min/mg for untreated protein), F87L (0.76±0.10 versus 0.22±0.03 mmol/min/mg for untreated protein), R103W (2.21±0.31 versus 0.84±0.07 mmol/min/mg for untreated protein), and D299N (2.68±0.30 versus 0.80±0.16 mmol/min/mg for untreated protein) were significantly stimulated by the ALDH2 activator Alda-1. A similar stimulation trend was observed with sodium pyruvate. However, R95C, R168C and K155T were not significantly stimulated by Alda-1 and pyruvate. Together, we identified new Black ALDH2 variants with reduced enzymatic activity. Alda-1 and pyruvate stimulated some but not all variants indicating that Alda-1 and pyruvate are not universal activators of ALDH2 variants. The identification of Black ALDH2 variants with reduced activity is an important step since the reduced activity of ALDH2 variants is linked to cardiovascular disease in Asians. This work was supported by NIH R35GM119522 (ERG) Genetic variants of ALDH2 found in Blacks cause inefficient acetaldehyde metabolism . The activity of wild type ALDH2 and Black ALDH2 variants were measured in the presence of 20μM Alda-1 or 1mM sodium pyruvate or vehicle. Alda-1 significantly activated wild type, I41V, F87L and D299N by 2.2-3.4-fold but did not significantly activate K155T relative to vehicle. Pyruvate significantly activated I41V and D299N by 1.6-2.3-fold but not F87L and K155T relative to vehicle, n=5/group, ^ p<0.01 with unpaired two-tailed Student's t-test relative to untreated.

Uncovering newly identified aldehyde dehydrogenase 2 genetic variants that lead to acetaldehyde accumulation after an alcohol challenge

Genetic Influences on Alcohol Flushing in East Asian Populations

Aldh2(E487k) Mutation Increases Protein Turnover and Promotes Murine Hepatocarcinogenesis

Glu504Lys Single Nucleotide Polymorphism of Aldehyde Dehydrogenase 2 Gene and the Risk of Human Diseases

ALDH2 variance in disease and populations

Acetaldehyde Enhances Alcohol Sensitivity and Protects against Alcoholism: Evidence from Alcohol Metabolism in Subjects with Variant ALDH2*2 Gene Allele

The Alcohol Flush Response

[Aldehyde Dehydrogenase (ALDH2) Polymorphism and Drinking Behavior].

Abstract 2211: ALDH2 deficiency and alcohol intake: Opportunity for precision cancer prevention

Overexpression of aldehyde dehydrogenase-2 (ALDH2) transgene prevents acetaldehyde-induced cell injury in human umbilical vein endothelial cells: role of ERK and p38 mitogen-activated protein kinase.

Novel aldehyde dehydrogenase 2 variants in Blacks affect acetaldehyde metabolism in vitro

Association Of Low-Activity Aldh2 And Alcohol Consumption With Risk Of Esophageal Cancer In Chinese Adults: A Population-Based Cohort Study

Cloning and Expression of Different Genotypes of Human Aldehyde Dehydrogenase 2 Gene

Origin and Dispersal of Atypical Aldehyde Dehydrogenase ALDH2⁎487Lys

Recombinant Expression of Aldehyde Dehydrogenase 2 (ALDH2) in Escherichia coli Nissle 1917 for Oral Delivery in ALDH2-Deficient Individuals

Genotype of Ethanol Metabolizing Enzyme Genes by Oligonucleotide Microarray in Alcoholic Liver Disease in Chinese People.

SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common ALDH2 alcohol flushing variant

Aldehyde dehydrogenase 2 deficiency reinforces formaldehyde-potentiated pro-inflammatory responses and glycolysis in macrophages

Attenuation of Acetaldehyde-Induced Cell Injury by Overexpression of Aldehyde Dehydrogenase-2 (ALDH2) Transgene in Human Cardiac Myocytes: Role of MAP Kinase Signaling.

Strong Protective Effect of the Aldehyde Dehydrogenase Gene (ALDH2) 504lys (*2) Allele Against Alcoholism and Alcohol-Induced Medical Diseases in Asians

Alcohol Consumption, Aldehyde Dehydrogenase 2 Gene Polymorphisms, and Cardiovascular Health in Korea